mani
studi
current
investig
develop
safe
effect
vaccin
prevent
variou
infecti
diseas
multipl
antigenpres
peptid
vaccin
system
develop
avoid
advers
effect
associ
convent
vaccin
ie
liveattenu
kill
inactiv
pathogen
carrier
protein
cytotox
adjuv
recent
two
main
approach
use
develop
multipl
antigenpres
peptid
vaccin
system
addit
function
compon
eg
tcell
epitop
cellpenetr
peptid
lipophil
moieti
synthet
approach
use
sizedefin
nanomateri
eg
selfassembl
peptid
nonpeptid
dendrim
gold
nanoparticl
antigendisplay
platform
review
summar
recent
experiment
studi
direct
develop
multipl
antigenpres
peptid
vaccin
system
latter
half
th
centuri
onward
vaccin
save
million
human
live
countless
anim
vaccinolog
contribut
prevent
infecti
diseas
eg
polio
measl
rubella
antiserum
toxoid
eg
snake
bite
spider
bite
jellyfish
sting
howev
strong
demand
develop
safer
effect
vaccin
toward
prevent
mani
infecti
diseas
eg
human
immunodefici
viru
hiv
malaria
group
streptococci
ga
hepat
c
viru
hcv
sever
acut
respiratori
syndrom
sar
also
cancer
immunotherapi
synthet
immunogen
peptid
ideal
vaccin
subunit
compon
follow
differ
tradit
vaccin
compos
liveattenu
kill
inactiv
pathogen
eg
bacteria
virus
infecti
materi
crossreact
host
tissu
induct
sitespecif
antibodi
ab
abil
chemic
defin
modifi
product
swift
largescal
manufactur
longterm
storag
event
pandem
howev
biolog
activ
peptid
gener
short
due
enzymat
degrad
small
peptid
use
antigen
recogn
immun
cell
eg
dendrit
cell
dc
macrophag
elicit
strong
immun
respons
administ
alon
coadministr
adjuv
eg
waterinoil
emuls
oilinwat
emuls
liposom
bacteri
lipophil
compound
etc
subunit
peptid
antigen
one
method
use
enhanc
immun
respons
howev
adjuv
approv
clinic
use
altern
short
antigen
peptid
induc
strong
immun
respons
coadministr
engag
carrier
protein
eg
ovalbumin
ova
bovin
serum
albumin
keyhol
limpet
hemocyanin
tetanu
toxoid
etc
howev
also
associ
undesir
effect
suppress
antipeptid
ab
respons
product
ab
carrier
protein
tam
develop
multipl
antigen
peptid
map
system
improv
poor
immunogen
subunit
peptid
vaccin
map
system
multipl
copi
antigen
peptid
simultan
bound
group
nonimmunogen
lysbas
dendrit
scaffold
figur
proteins
map
molecul
acquir
stabil
enzymat
degrad
enhanc
molecular
recognit
immun
cell
induct
stronger
immun
respons
compar
small
antigen
peptid
map
concept
repres
major
breakthrough
vaccin
system
improv
larg
varieti
multipl
antigenspres
peptid
vaccin
system
investig
review
focus
current
statu
multipl
antigenpres
vaccin
approach
especi
addit
function
compon
applic
wide
varieti
synthet
method
sizedefin
nanomateri
eg
selfassembl
peptid
dendrim
gold
nanoparticl
antigendisplay
platform
tam
map
vaccin
carri
sever
copi
peptid
antigen
lysbas
dendrim
induc
higher
ab
product
singl
peptid
monom
carrier
proteinpeptid
conjug
howev
addit
compon
adjuv
requir
mani
case
therefor
great
effort
direct
toward
improv
map
vaccin
incorpor
variou
function
singl
vaccin
molecul
use
helper
tcell
epitop
immunestimul
lipid
moieti
cellpenetr
peptid
conduct
incorpor
helper
tcell
epitop
map
vaccin
investig
map
vaccin
contain
band
tcell
epitop
singl
construct
induc
strong
immun
respons
studi
clinic
trial
although
singl
vaccin
molecul
contain
band
tcell
epitop
induc
product
ab
defin
tcell
epitop
case
ab
titer
antitcel
epitop
mostli
lower
bcell
epitop
lipophil
modif
wide
varieti
cell
includ
bcell
tcell
dc
macrophag
express
tolllik
receptor
tlr
surfac
eleven
tlr
name
simpli
human
identifi
date
tlr
famili
patternrecognit
receptor
recogn
structur
compon
mani
bacteria
virus
fungi
play
critic
role
earli
innat
immun
respons
tlrmediat
stimul
apc
significantli
enhanc
secret
proinflammatori
cytokin
ab
product
immun
respons
tlr
agonist
may
abl
use
altern
adjuv
system
bacteri
lipid
compon
inner
outer
membran
compon
gramneg
bacteria
lipid
compon
macrophageactiv
lipopeptid
isol
mycoplasma
well
synthet
amino
acid
character
agonist
use
immunestimul
lipophil
moieti
figur
attach
antigen
peptid
lipopeptid
lipophil
compound
oacyl
serin
nacyl
lysin
glycolipid
also
util
purpos
lipopeptid
stimul
innat
immun
interact
tlr
dc
elicit
longlast
system
immun
respons
tcell
prolifer
result
enhanc
immunogen
unmodifi
peptid
order
magnitud
addit
lipopeptid
show
none
harm
side
effect
adjuv
lipopeptid
vaccin
current
preclin
clinic
trial
treat
hiv
hepat
b
viru
incorpor
lipid
known
immunestimul
characterist
map
system
produc
selfadjuv
lipopeptid
vaccin
candid
induc
ab
cellular
respons
absenc
addit
adjuv
membran
identifi
name
cellpenetr
peptid
cpp
cpp
studi
abil
deliv
peptidesprotein
oligonucleotidesdnarna
even
much
bigger
molecul
liposom
cytoplasm
cell
fulli
exploit
abil
cpp
util
vaccin
studi
deliveri
antigen
apc
aim
antigen
present
induct
immun
respons
cppantigen
conjug
enhanc
crosspenetr
antigen
dc
howev
cpp
function
cell
type
dual
function
compound
cpp
conjug
dc
target
design
one
studi
show
synergist
enhanc
immun
respons
numer
attempt
incorpor
variou
function
compon
singl
molecul
perform
one
consider
design
multipl
antigenpres
vaccin
compos
variou
compon
molecular
geometri
ie
alter
linkag
spatial
arrang
compon
evid
influenc
conform
structur
lack
solubl
molecular
recognit
immun
cell
zeng
et
al
studi
influenc
divers
chemic
linkag
epitop
orient
immunolog
activ
either
nterminu
cterminu
tcell
epitop
bcell
epitop
link
via
disulf
thioether
oxim
peptid
bond
immunolog
evalu
epitopecontain
molecul
differ
linkag
show
uniqu
properti
term
stabil
serum
abil
induc
ab
tcell
bcell
epitop
abdela
et
al
studi
relationship
immunolog
activ
structur
arrang
multipl
antigenspres
vaccin
molecul
compon
bcell
epitop
tcell
epitop
amino
acid
show
clearli
chang
posit
compon
significantli
affect
product
igg
ab
bcell
epitop
case
tcell
epitop
case
map
system
number
peptid
epitop
incorpor
lysbas
dendrit
scaffold
limit
furthermor
stepwis
solid
phase
peptid
synthesi
spp
branch
peptid
map
commonli
encount
difficulti
purif
homogen
character
final
product
use
purifi
short
peptid
build
block
sever
chemoselect
conjug
techniqu
e
g
nativ
chemic
ligat
thioether
ligat
thiazolidineoxazolidin
ligat
oxim
ligat
maleimid
cu
catalyz
azidealkyn
cycloaddit
appli
synthesi
multipl
antigenpres
vaccin
howev
difficulti
associ
stoichiometr
stepwis
incorpor
mani
differ
peptid
epitop
lysbas
dendrit
scaffold
remain
concern
design
prepar
biolog
activ
multipl
antigenpres
vaccin
molecul
stoichiometr
epitop
densiti
multival
ligand
import
paramet
henc
introduc
altern
synthet
approach
use
attach
multipl
copi
antigen
peptid
onto
organ
inorgan
scaffold
instead
lysbas
dendrim
polym
chemistri
use
purifi
antigen
peptid
suitabl
prepar
multipl
antigenpres
vaccin
molecul
free
radicalinduc
polymer
vinyl
monom
one
common
use
reaction
make
polym
acryloyl
ch
chco
group
key
function
group
polymer
easili
introduc
peptid
convent
spp
free
radicalinduc
polymer
acryloylpeptid
build
block
yield
polymer
immunogen
bear
hundr
differ
peptid
figur
size
polym
construct
distanc
individu
peptid
compon
control
addit
acrylamid
analog
along
chain
transfer
agent
dithiothreitol
mercaptoacet
acid
polymer
process
jackson
et
al
evalu
vaccin
efficaci
polymer
immunogen
contain
bcell
epitop
ntermin
ga
protein
sequenc
chimer
peptid
bcell
epitop
consist
ga
mprotein
cregion
dnabind
protein
sequenc
polymer
ga
vaccin
molecul
show
outstand
broad
immunogen
protect
ga
infect
mice
ab
individu
epitop
present
polym
success
elicit
selfassembl
nanoparticl
antigenpres
platform
peptid
certain
helic
secondari
structur
assembl
form
tubular
fibrillar
spheric
structur
nanoscal
via
noncoval
interact
eg
van
der
waal
bond
electrostat
interact
hydrogen
bond
stack
interact
call
selfassembl
peptid
appli
topolog
defin
build
block
variou
field
includ
materi
scienc
molecular
electron
tissu
engin
drug
deliveri
abil
selfassembl
peptid
form
nanostructur
also
great
interest
repetit
antigen
display
system
figur
burkhard
group
use
selfassembl
peptid
nanoparticl
compos
pentamer
coiledcoil
oligomer
domain
deriv
cartilag
oligomer
matrix
protein
de
novo
trimer
coiledcoil
oligomer
domain
multipl
antigendisplay
platform
coiledcoil
bcell
epitop
deriv
sar
protein
attach
selfassembl
peptid
nanoparticl
selfassembl
phosphatebuff
salin
yield
nanoparticl
nm
diamet
expos
multipl
copi
surfac
circular
dichroism
cd
spectra
indic
peptid
nanoparticl
maintain
conform
immunolog
evalu
nanoparticl
contain
show
specif
ab
product
moder
neutral
activ
sar
coronaviru
infect
furthermor
immun
mice
peptid
nanoparticl
bear
malaria
bcell
epitop
dppppnpn
success
induc
high
ab
titer
longlast
protect
major
mice
protect
initi
challeng
parasit
month
last
immun
month
second
challeng
selfassembl
peptid
nanoparticl
vaccin
malaria
current
undergo
preclin
trial
us
short
fibril
peptid
selfassembl
saltcontain
aqueou
solut
form
network
nanofib
width
nm
result
nanoparticl
noncytotox
minim
immunogen
rudra
et
al
use
multipl
antigenpres
vaccin
system
selfassembl
peptid
nanofib
ova
epitop
deriv
chicken
egg
ova
link
via
spacer
subcutan
administr
mice
elicit
high
igg
titer
absenc
addit
adjuv
ab
titer
remark
higher
compar
admixtur
ova
complet
freund
adjuv
cfa
accord
studi
ab
titer
determin
even
coadministr
cfa
usag
selfassembl
nonpeptid
dendrit
polym
antigendisplay
system
recent
report
multipl
copi
bcell
epitop
ga
mprotein
attach
dendrim
via
cu
catalyz
azidealkyn
cycloaddit
subsequ
selfassembl
carri
water
form
nanoparticl
nm
diamet
subcutan
immun
nanomolecul
sever
figur
vaccin
molecul
present
number
epitop
alkyl
backbon
form
free
radicalinduc
polymer
acryloyl
group
subclass
igg
success
produc
without
adjuv
gold
nanoparticl
antigen
carrier
altern
organ
compound
certain
peptid
polym
inorgan
materi
sio
ag
pt
au
also
known
form
nanoparticl
colloid
gold
nanoparticl
gnp
interest
variou
biomed
applic
eg
imag
photoactiv
therapeut
tumor
detect
drug
deliveri
well
multival
antigen
carrier
scaffold
instead
convent
carrier
protein
synthet
dendrimerspolym
gnp
ideal
materi
primarili
biocompat
lack
immunogen
gnp
easili
prepar
gold
salt
h
aucl
water
particl
size
control
rang
nm
diamet
consequ
gold
surfac
electrod
readili
react
molecul
bear
mercapto
sh
group
figur
strong
attach
mercapto
group
gold
surfac
easili
prepar
well
chemoselect
conjug
eg
nativ
chemic
ligat
click
chemistri
oxim
ligat
thioether
ligat
antigen
peptid
synthet
core
particl
sophist
case
sizedepend
toxic
nake
gnp
reduc
modifi
surfac
intracellular
uptak
gnp
mediat
endocytosi
enabl
gnp
deliv
attach
molecul
cell
gnppeptid
conjug
resist
enzymat
lysosom
degrad
gnp
suitabl
materi
use
antigenpres
scaffold
chen
et
al
demonstr
addit
extra
cy
residu
cterminu
epitop
deriv
protein
footandmouth
diseas
viru
allow
conjug
differ
size
gnp
antigen
carrier
mice
immun
gnpepitop
conjug
show
signific
sizedepend
immunogen
biodistribut
spleen
conjug
fc
fragment
human
igg
target
receptor
human
dc
gnp
success
enhanc
cellular
uptak
antigen
addit
gnpepitopefc
conjug
show
better
antigenuptak
activ
immunolog
respons
lymphocyt
prolifer
compar
use
liposom
antigendeliveri
system
current
statu
multipl
antigenspres
vaccin
system
review
variou
function
compon
thelper
epitop
immunestimul
lipid
cellpenetr
peptid
attach
antigen
improv
subunit
peptid
vaccin
potenti
effect
select
activ
particular
immun
system
mucos
immun
meanwhil
recent
use
sizedefin
organ
inorgan
nanomateri
without
either
immunogen
cytotox
antigendisplay
platform
sure
advanc
develop
subunit
peptid
vaccin
without
use
adjuv
nanomateri
antigendisplay
platform
howev
shortcom
requir
sever
synthet
step
cost
optim
balanc
vaccin
efficaci
amount
ratio
attach
bepitop
addit
function
compon
explor
altern
safe
econom
materi
multipl
antigenpres
system
instead
au
would
help
reduc
cost
practic
use
optim
balanc
continu
investig
antigendisplay
platform
would
ideal
compon
develop
vaccin
work
support
grantsinaid
young
scientist
b
ministri
educ
cultur
sport
scienc
technolog
japan
yf
author
contribut
yf
draft
manuscript
ht
help
draft
manuscript
author
read
approv
final
manuscript
author
declar
compet
interest
